Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis

NCT00913133 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
516
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Canyon Pharmaceuticals, Inc.